ST Bailing (002424.SZ) subsidiary's Tangning Tongluo Cream approved for clinical trials

Zhitong Finance APP News, ST Bailing (002424.SZ) announced that recently, its wholly-owned subsidiary Bailing Yuxiu (Zhuhai) Pharmaceutical Co., Ltd. (referred to as "Bailing Yuxiu") received the "Drug Clinical Trial Approval Notice" approved and issued by the National Medical Products Administration. The company's clinical trial application for Tangning Tongluo Cream meets the relevant requirements for drug registration. On the basis of further improving the clinical trial protocol, it is agreed to conduct clinical trials for the treatment of diabetic foot ulcers.